Sakar Healthcare DuPont analysis

·UnclassifiedChart ›

Profitability Growth Credit Liquidity Working capital Dividend yield DuPont CAGR

Per cent unless marked ×

Tap a line for its trend	Last 12Mto Sep 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

5-step DuPont — ROE = tax burden × interest burden × EBIT margin × turnover × leverage						FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	0.72×	0.77×	0.81×	0.73×	0.76×
	0.92×	0.88×	0.75×	0.78×	0.93×
	21.5%	18.0%	16.2%	13.2%	13.6%
	0.56×	0.56×	0.44×	0.42×	0.44×
	1.49×	1.48×	1.45×	1.48×	1.94×
	11.9%	10.1%	6.3%	4.7%	8.2%
	10.0%	10.0%	6.4%	5.4%	8.5%

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

SAKAR₹946.50

Sakar Healthcare Limited

· Unclassified

₹ CrorePeersMACPOWER SERVOTECH KAPSTON THEJOBETAMcap ₹2,106 Cr

Profitability Growth Credit Liquidity Working Capital Yield Analysis DuPont

Ratios — % unless marked × 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/09/2026
5-Step DuPont — ROE = Tax Burden × Interest Burden × EBIT Margin × Turnover × Leverage
Tax Burden (Net Income/Pretax) ×	0.76	0.73	0.81	0.77	0.72
Interest Burden (Pretax/EBIT) ×	0.93	0.78	0.75	0.88	0.92
EBIT Margin %	13.61	13.25	16.22	18.00	21.53
Asset Turnover ×	0.44	0.42	0.44	0.56	0.56
Financial Leverage (Assets/Equity) ×	1.94	1.48	1.45	1.48	1.49
ROE (5-step product, year-end total equity) %	8.17	4.74	6.31	10.05	11.85
ROE (owners' profit / average owners' equity) %	8.48	5.36	6.39	10.00	10.00

No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.